21.6 C
London
Friday, June 21, 2024

Emerging Growth Conference 73 - July 17 & 18, 2024 - Register now

Emerging Growth Conference 72

June 12 & 13, 2024

Agenda Wednesday June 12, 2024

Perfect Corp. (NYSE: PERF) works with over 600 partners around the globe to empower brands to embrace the digital-first world by transforming shopping journeys through digital tech innovations.

Keynote speaker: Louis Chen, EVP, CSO

Intellabridge Technology Corporation (CSE: KASH) (OTCQB: KASHF) (FSE: KASH) is a fintech company in the business of impact finance whose product, Karma, has a mission to make every transaction have a positive impact on the world through cashback solutions and automated customizable donations to charitable organizations.

Keynote speaker: John Eagleton, CEO

Pulsar Helium, Inc.’s (OTCQB: PSRHF) (TSXV: PLSR) portfolio consists of the Topaz helium project in Minnesota, USA and the Tunu helium project in Greenland. Pulsar is the first mover in both locations with primary helium occurrences not associated with the production of hydrocarbons identified at each.

Keynote speaker: Thomas Abraham-James President / CEO

Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) is developing tecarfarin for unmet needs in anticoagulation therapy.

Keynote speaker: Mr. Quang X. Pham, Chairman & CEO

LogicMark, Inc. (NASDAQ: LGMK) provides personal emergency response systems (PERS), health communications devices, personal safety apps, services, and technologies to create a Connected Care Platform.

Keynote speaker: Ms. Chia-Lin Simmons, CEO

Unusual Machines, Inc. (NYSE American: UMAC) manufactures and sells drone components and drones across a diversified brand portfolio, which includes Fat Shark, the leader in FPV (first-person view) ultra-low latency video goggles for drone pilots. 

Keynote speaker: Allan Evans, CEO

SeaStar Medical Holding Corporation (NASDAQ: ICU) is a commercial-stage medical technology company that is redefining how extracorporeal therapies may reduce the consequences of excessive inflammation on vital organs. 

Keynote speaker: Eric Schlorff, President / CEO, Director

Diakonos Oncology, Inc., a recipient of FDA’s Fast Track designation, is a clinical-stage biotechnology company developing a groundbreaking Dendritic Cell Vaccine (DCV) for difficult-to-treat cancers.

Keynote speakers: Jay Hartenbach, COO, & Anthony Baldor, CFO & Head of Business Development

Longeveron, Inc. (NASDAQ: LGVN) is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs.

Keynote speaker: Mohamed Wa’el Hashad, CEO & Director

Clene Inc., (NASDAQ: CLNN) is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson’s disease, and multiple sclerosis. 

Keynote speaker: Rob Etherington, President / CEO, & Morgan Brown, CFO

SenesTech, Inc. (NASDAQ: SNES), Inventors of ContraPest, the only U.S. EPA-registered contraceptive for male and female rats, is committed to improving the health of the world by humanely managing animal pest populations through fertility control.

Keynote speaker: Joel L. Fruendt, President, CEO, & Director

ASP Isotopes Inc. (NASDAQ: ASPI) is a pre-commercial stage advanced materials company dedicated to the development of technology and processes to produce isotopes for use in multiple industries.

Keynote speaker: Paul Elliot Mann, CEO

Agenda Thursday June 13, 2024

FBR, Ltd. (OTCQB: FBRKF) (ASX: FBR) designs, develops, builds and operates dynamically stabilised robots to address global needs. 

Keynote speaker: Michael John Pivac, CEO & Managing Director

Huize Holding Limited (NASDAQ: HUIZ) is a leading insurance technology platform connecting consumers, insurance carriers and distribution partners digitally through data-driven and AI-powered solutions in China.

Keynote speaker: Mr. Ron Tam, Co CFO

Ascend Wellness Holdings Inc. (OTCQX: AAWH) owns and operates state-of-the-art cultivation facilities, growing award-winning strains and producing a curated selection of products for retail and wholesale customers

Keynote speaker: Rebecca Koar, EVP of Investor Relations and Strategy

Targa Exploration Corp. (CSE: TEX) (OTCQB: TRGEF) is a Canadian exploration company engaged in the acquisition, exploration, and development of lithium and gold mineral properties with headquarters in Vancouver, British Columbia.

Keynote speaker: Cameron Tymstra, President & CEO

Sucro Limited (TSXV: SUG) (OTCQB: SUGCF) is a growth-oriented, highly integrated and interconnected sugar company that operates throughout the Americas, with a primary focus on serving the North American sugar market.

Keynote speaker: Don Hill, Chairman

Patriot AG Corp. is a private company run by the Severson family who migrated from Norway to North Dakota in 1895. They settled in the prairies in Canada and present a 6th generation grain farm composing of 4.100 owned acres & 1.900 rented acres. of which, they are focused on growing barley, beans, canola, peas, wheat. 

Keynote speaker: Eric Till, CEO / CFO, & Kyle Severson, COO

Atara Biotherapeutics, Inc. (NASDAQ: ATRA) is harnessing the natural power of the immune system to develop off-the-shelf cell therapies for difficult-to-treat cancers and autoimmune conditions that can be rapidly delivered to patients from inventory. 

Keynote speaker: Jason Awe, Head of Corporate Communications & IR

Bioxytran, Inc. (OTCQB: BIXT) is a clinical stage biotechnology company developing novel therapies targeting the treatment of significant unmet medical needs in virology, degenerative disease, and hypoxia. 

Keynote speakers: David Platt, CEO & Mike Sheikh, Executive Vice President Business Development

InMed Pharmaceuticals, Inc. (NASDAQ: INM) is a clinical stage pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates targeting the CB1/CB2 receptors.

Keynote speaker: Eric Adams, CEO

Immuron Limited (NASDAQ: IMRN), is a  biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the treatment of infectious diseases.

Keynote speaker: Steve Lydeamore, CEO

Citizens, Inc. (NYSE: CIA) is a diversified financial services company providing life, living benefits and final expense insurance and other financial products to individuals and small businesses in the U.S., Latin America, and Asia.

Keynote speakers: Gerald W. Shields, Vice Chairman and CEO Jeff Conklin, CFO

Digital Brand Media & Marketing Group, Inc. (OTC Pink: DBMM) is a fully reporting US public holding company whose 100%-owned/operating subsidiary and brand, Digital Clarity, is a leading digital marketing management consultancy helping B2B technology leaders achieve business growth through a series of marketing strategies that have been developed over 2 decades.

Keynote speaker: Reggie James, COO, Sr. VP & Exec. Director

ATRenew Inc. (NYSE: RERE) operates a leading technology-driven pre-owned consumer electronics transactions and services platform in China under the brand ATRenew.

Keynote speakers: Jessie Jin, Investor Relations Manager & Jeremy Ji, Director of Corporate Development & Investor Relations

Meihua International Medical Technologies Co. (NASDAQ: MHUA) is a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China

Keynote speaker: Mr. Steven Wang, CEO

GTI Energy, Ltd. (OTC Pink: GTRIF) (ASX: GTR) is part of Wyoming’s Insitu Recovery (ISR) uranium mining renaissance, focused on exploring for, defining and developing economic ISR Uranium resources.

Keynote speaker: Bruce Lane, Executive Director, CEO

The Emerging Growth Conference focus and coverage includes a wide range of growth sectors and timely market themes, including, augmented reality, artificial intelligence, scientific, medical instruments and therapeutics, biotechnologies, cannabis, food & beverage, energy and more.

Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients.  Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future.  In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally.

The presentations to be delivered by the presenting companies (including any handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with the offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.

Thank you for your interest in our conference, and we look forward to your participation in future conferences.